Martin W. Lunnon

Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache

Hans Olav Høivik, Bart Laurijssens, Lutz Harnisch et al. · Cephalalgia · 2010 · 90 citations

Safety and Tolerability of 619C89 after Acute Stroke

Keith W. Muir, Steven Hamilton, Martin W. Lunnon et al. · Cerebrovascular Diseases · 1998 · 83 citations

Does the Unfavorable Pharmacokinetic and Pharmacodynamic Profile of the iNOS Inhibitor GW273629 Lead to Inefficacy in Acute Migraine?

Bart Van der Schueren, Martin W. Lunnon, Bart Laurijssens et al. · The Journal of Clinical Pharmacology · 2009 · 38 citations

Pharmacotherapy, Pharmacokinetics, Medicinal Chemistry +18

Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis

Valérie Wibaut-Berlaimont, Anna M. Randi, Martin W. Lunnon et al. · Journal of Thrombosis and Haemostasis · 2005 · 36 citations · Full text

Cell Death, Pathology, Hyperlipidemia +17

Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions

Sara Armani, Andreas Geier, Thomas Först et al. · British Journal of Clinical Pharmacology · 2023 · 26 citations · Full text